Study of UX003 Recombinant Human Beta-Glucuronidase (rhGUS) Enzyme Replacement Treatment in Mucopolysaccharidosis Type 7, Sly Syndrome (MPS 7) Patients Less Than 5 Years of Age

Clinical trial NCT02418455 · COMPLETED

Trial details

NCT number: NCT02418455
Sponsor: Ultragenyx Pharmaceutical Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sly Syndrome MPS VII Mucopolysaccharidosis Mucopolysaccharidosis VII

Start date: 2015-07-21
Primary completion: 2019-03-26
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.